Cell Therapy Manufacturing Market, By Therapy Type (Allogeneic Cell Therapy and Autologous Cell Therapy), By Technology Type (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, 3D Technology), By Manufacturing Purpose (Clinical, Commercial, Pre-clinical), By Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
In October 2023, Bayer AG, a pharmaceutical company, announced the opening of its first Cell Therapy Launch Facility in Berkeley, California, U.S. to create the capacity to bring cell therapies to patients on a global scale
In May 2020, Takara Bio Inc., a biotechnology company, launched a new facility- the Center for Gene and Cell Therapy Processing II (CGCPII) in Shiga, Japan